Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A Dimitrios ColevasMarshall R Posner

Abstract

A phase I/II trial of docetaxel, cisplatin, fluorouracil (5-FU), and leucovorin (TPFL5) induction chemotherapy for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Twenty-three previously untreated patients with stage III or IV SCCHN and Eastern Cooperative Oncology Group functional status less than or equal to 2 were treated with TPFL5. Postchemotherapy home support included intravenous fluids, prophylactic antibiotics, and granulocyte colony-stimulating factor (G-CSF). Docetaxel dose was escalated to determine the maximum-tolerated dose (MTD). Fifteen patients were treated with three cycles of TPFL5 at MTD. Patients who achieved either a partial response (PR) or complete response (CR) to three cycles of TPFL5 then received definitive twice-daily radiation therapy. Toxicity and clinical and pathologic response to TPFL5 were assessed. Twenty-three patients received a total of 69 cycles of TPFL5. The MTD was determined to be docetaxel 60 mg/m2. Dose-limiting toxicity (DLT) was neutropenia. Additional significant toxicities at MTD were nausea, mucositis, diarrhea, peripheral neuropathy, and sodium-wasting nephropathy. The overall response rate to TPFL5 was 100%, which included 14 of 23 (61%) cl...Continue Reading

Citations

Mar 26, 2009·Journal of the National Cancer Institute·Yoann PointreauGilles Calais
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Janinis, G Panagos
Jul 8, 2000·The Oncologist·D Schrijvers, J B Vermorken
Oct 6, 2006·Expert Review of Anticancer Therapy·Eloy RomanEdgardo S Santos
Mar 1, 2007·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Young-Jin ChoiChang-Hak Sohn
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A D ColevasM R Posner
Mar 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Christopher HolsingerFadlo R Khuri
Mar 25, 2006·Future Oncology·Dirk Schrijvers, Jan B Vermorken
Sep 1, 2007·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jae-Sook AhnIk-Joo Chung
Jan 31, 2003·British Journal of Cancer·M R Posner, J L Lefebvre
Oct 29, 2004·The Laryngoscope·George H YooJohn F Ensley
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W F RegineM Mohiuddin
Dec 17, 2010·Anti-cancer Drugs·Yoann PointreauJean Louis Lefebvre
May 6, 2009·American Journal of Clinical Oncology·Joseph I ClarkBahman Emami
Oct 22, 1998·American Journal of Clinical Oncology·A D Colevas, M R Posner
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R PosnerC A Garay
Jan 11, 2012·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Shun-ichi ChitoseHiromasa Fujita
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·Y ChenH D Suit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.